Fukunaga Toshiki, Ohta Ryuichi, Yamane Fumiko, Sano Chiaki
Family Medicine, Faculty of Medicine, Shimane University, Izumo, JPN.
Community Care, Unnan City Hospital, Unnan, JPN.
Cureus. 2022 Jun 23;14(6):e26257. doi: 10.7759/cureus.26257. eCollection 2022 Jun.
Adult-onset Still's disease (AOSD) is a systemic inflammatory disease characterized by rash, arthritis, and persistent spiking fever. The diagnosis and treatment of AOSD are challenging due to the lack of specific diagnostic criteria and little evidence of effective treatments. Here, we reported a case of an 18-year-old woman with a fever of unknown origin (FUO), evanescent rash (without the typical "salmon-pink" color), and systemic lymphadenopathy. Laboratory tests at hospital admission revealed marked hyperferritinemia of 12,100 ng/mL. AOSD was subsequently suspected. Additional anti-nuclear-antibody analysis for differential diagnosis was negative. The initiation treatment with high-dose prednisolone, tapered to half every week, was immediately started. The symptoms temporarily improved but relapsed during the tapering period. The prednisolone dose was increased again, and tocilizumab was introduced. Symptom remission and prednisolone dose reduction were subsequently achieved. Therefore, a medication tapering schedule and treatment replacement to inhibit the pathophysiology of AOSD need to be carefully considered. While a ferritin test is useful to diagnose AOSD based on the presence of FUO, there are AOSD patients without hyperferritinemia. Additionally, AOSD rash on Asian skin may not present with the typical "salmon-pink" color.
成人斯蒂尔病(AOSD)是一种全身性炎症性疾病,其特征为皮疹、关节炎和持续性高热。由于缺乏特异性诊断标准且有效治疗的证据较少,AOSD的诊断和治疗具有挑战性。在此,我们报告了一例18岁女性患者,她有不明原因发热(FUO)、一过性皮疹(无典型的“鲑鱼粉红色”)和全身淋巴结肿大。入院时的实验室检查显示铁蛋白显著升高,达12,100 ng/mL。随后怀疑为AOSD。用于鉴别诊断的额外抗核抗体分析为阴性。立即开始使用大剂量泼尼松龙治疗,每周减量一半。症状暂时改善,但在减量期间复发。泼尼松龙剂量再次增加,并加用托珠单抗。随后实现了症状缓解和泼尼松龙剂量减少。因此,需要仔细考虑抑制AOSD病理生理的药物减量方案和治疗替代方法。虽然基于FUO的存在,铁蛋白检测对诊断AOSD有用,但也有AOSD患者没有高铁蛋白血症。此外,亚洲人皮肤的AOSD皮疹可能不会呈现典型的“鲑鱼粉红色”。